{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:51:31Z","timestamp":1787791891573,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.jsat.2016.02.009","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T23:31:59Z","timestamp":1457479919000},"page":"48-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"special_numbering":"C","title":["Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification"],"prefix":"10.1016","volume":"66","author":[{"given":"Lisa A.","family":"Uebelacker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genie","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2016.02.009_bb0005","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13722-015-0034-5","article-title":"Factors associated with willingness to take extended release naltrexone among injection drug users","volume":"10","author":"Ahamad","year":"2015","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2016.02.009_bb0010","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jsat.2013.04.002","article-title":"Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification","volume":"45","author":"Bailey","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"Suppl. 8","key":"10.1016\/j.jsat.2016.02.009_bb0015","first-page":"S235","article-title":"Cost and utilization outcomes of opioid-dependence treatments","volume":"17","author":"Baser","year":"2011","journal-title":"American Journal of Managed Care"},{"key":"10.1016\/j.jsat.2016.02.009_bb0020","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jsat.2015.04.002","article-title":"Patient perspectives associated with intended duration of buprenorphine maintenance therapy","volume":"56","author":"Bentzley","year":"2015","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.02.009_bb0025","article-title":"Long term substitution treatment (maintenance treatment) of opioid dependent persons. GMS\u201d","volume":"3","author":"Busch","year":"2007","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.jsat.2016.02.009_bb0030","series-title":"A Treatment Improvement Protocol (TIP) Series 43","article-title":"Medication-assisted treatment for opioid addiction in opioid treatment programs","author":"Center for Substance Abuse Treatment","year":"2005"},{"key":"10.1016\/j.jsat.2016.02.009_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta11090","article-title":"Methadone and buprenorphine for the management of opioid dependence: A systematic review and economic evaluation","volume":"11","author":"Connock","year":"2007","journal-title":"Health Technology Assessment"},{"key":"10.1016\/j.jsat.2016.02.009_bb0040","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.drugpo.2010.01.010","article-title":"Quality of life among opiate-dependent individuals: A review of the literature","volume":"21","author":"De Maeyer","year":"2010","journal-title":"The International Journal on Drug Policy"},{"key":"10.1016\/j.jsat.2016.02.009_bb0045","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.drugalcdep.2013.10.011","article-title":"Changes in quality of life (WHOQOL-BREF) and addiction severity index (ASI) among participants in opioid substitution treatment (OST) in low and middle income countries: An international systematic review","volume":"134","author":"Feelemyer","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.02.009_bb0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1521-0391.2012.12004.x","article-title":"Patient perspectives on choosing buprenorphine over methadone in an urban, equal-access system","volume":"22","author":"Gryczynski","year":"2013","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2016.02.009_bb0055","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scandinavian Journal of Statistics"},{"key":"10.1016\/j.jsat.2016.02.009_bb0060","doi-asserted-by":"crossref","first-page":"77","DOI":"10.7326\/0003-4819-154-2-201101180-00004","article-title":"Culturally appropriate storytelling to improve blood pressure: A randomized trial","volume":"154","author":"Houston","year":"2011","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2016.02.009_bb0065","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1080\/10810730.2011.551997","article-title":"The art and science of patient storytelling-harnessing narrative communication for behavioral interventions: The ACCE project","volume":"16","author":"Houston","year":"2011","journal-title":"Journal of Health Communication"},{"key":"10.1016\/j.jsat.2016.02.009_bb0070","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000219524","article-title":"Shared decision-making reduces drug use and psychiatric severity in substance-dependent patients","volume":"78","author":"Joosten","year":"2009","journal-title":"Psychotherapy and Psychosomatics"},{"key":"10.1016\/j.jsat.2016.02.009_bb0075","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1080\/02791072.2006.10399832","article-title":"Predicting treatment retention with a brief \u201cOpinions About Methadone\u201d scale","volume":"38","author":"Kayman","year":"2006","journal-title":"Journal of Psychoactive Drugs"},{"key":"10.1016\/j.jsat.2016.02.009_bb0080","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S0140-6736(11)60358-9","article-title":"Injectable extended-release naltrexone for opioid dependence: A double-blind, placebo-controlled, multicentre randomised trial","volume":"377","author":"Krupitsky","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.jsat.2016.02.009_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12874-015-0010-5","article-title":"Consistency between stated and revealed preferences: A discrete choice experiment and a behavioural experiment on vaccination behaviour compared","volume":"15","author":"Lambooij","year":"2015","journal-title":"BMC Medical Research Methodology"},{"key":"10.1016\/j.jsat.2016.02.009_bb0090","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1161\/CIRCOUTCOMES.113.000322","article-title":"Shared decision making: State of the science","volume":"7","author":"Lin","year":"2014","journal-title":"Circulation. Cardiovascular Quality and Outcomes"},{"key":"10.1016\/j.jsat.2016.02.009_bb0095","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1192\/pb.28.2.47","article-title":"Treatment preferences of opiate-dependent patients","volume":"28","author":"Luty","year":"2004","journal-title":"Psychiatric Bulletin"},{"key":"10.1016\/j.jsat.2016.02.009_bb0100","first-page":"CD002207","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.jsat.2016.02.009_bb0105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0740-5472(02)00246-5","article-title":"Detoxification as a gateway to long-term treatment: Assessing two interventions","volume":"23","author":"Millery","year":"2002","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.02.009_bb0110","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jsat.2010.07.009","article-title":"The SUMMIT trial: A field comparison of buprenorphine versus methadone maintenance treatment","volume":"39","author":"Pinto","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.02.009_bb0115","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.jsat.2008.09.007","article-title":"Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence","volume":"37","author":"Ridge","year":"2009","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.02.009_bb0120","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsat.2006.09.002","article-title":"Client and counselor attitudes toward the use of medications for treatment of opioid dependence","volume":"32","author":"Rieckmann","year":"2007","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2016.02.009_bb0125","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1080\/08897077.2011.600122","article-title":"The substance abuse counseling workforce: Education, preparation, and certification","volume":"32","author":"Rieckmann","year":"2011","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2016.02.009_bb0130","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/109019818801500203","article-title":"Social learning theory and the health belief model","volume":"15","author":"Rosenstock","year":"1988","journal-title":"Health Education Quarterly"},{"key":"10.1016\/j.jsat.2016.02.009_bb0135","doi-asserted-by":"crossref","DOI":"10.1007\/s40271-015-0115-2","article-title":"The predictive value of discrete choice experiments in public health: An exploratory application","author":"Salampessy","year":"2015","journal-title":"Patient"},{"key":"10.1016\/j.jsat.2016.02.009_bb0140","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1080\/10550490802268835","article-title":"Attitudes toward buprenorphine and methadone among opioid-dependent individuals","volume":"17","author":"Schwartz","year":"2008","journal-title":"American Journal on Addictions"},{"key":"10.1016\/j.jsat.2016.02.009_bb0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2011.10.016","article-title":"The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone","volume":"123","author":"Stein","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2016.02.009_bb0150","series-title":"NSDUH Series H-46, HHS Publication No. (SMA) 13\u20134795","article-title":"Results from the 2012 National Survey on Drug Use and health: Summary of National Findings","author":"Substance Abuse and Mental health Services Administration","year":"2013"},{"key":"10.1016\/j.jsat.2016.02.009_bb0155","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMp1402780","article-title":"Medication-assisted therapies--Tackling the opioid-overdose epidemic","volume":"370","author":"Volkow","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2016.02.009_bb0160","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1111\/j.1360-0443.2010.03028.x","article-title":"Using theories of behaviour change to inform interventions for addictive behaviours","volume":"105","author":"Webb","year":"2010","journal-title":"Addiction"},{"key":"10.1016\/j.jsat.2016.02.009_bb0165","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0976-3147.91934","article-title":"Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds","volume":"3","author":"Whelan","year":"2012","journal-title":"Journal of Neurosciences in Rural Practice"},{"key":"10.1016\/j.jsat.2016.02.009_bb0170","series-title":"Narcotics anonymous and the pharmacotherapeutic treatment of opioid addiction in the United States","author":"White","year":"2011"},{"key":"10.1016\/j.jsat.2016.02.009_bb0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.drugpo.2010.08.001","article-title":"\"Should I stay or should I go?\" Coming off methadone and buprenorphine treatment","volume":"22","author":"Winstock","year":"2011","journal-title":"The International Journal on Drug Policy"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216000490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547216000490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:44:29Z","timestamp":1760039069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547216000490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":35,"alternative-id":["S0740547216000490"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2016.02.009","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patients' Beliefs About Medications are Associated with Stated Preference for Methadone, Buprenorphine, Naltrexone, or no Medication-Assisted Therapy Following Inpatient Opioid Detoxification","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2016.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}